GRK2 and obesity disorder: To directly address whether GRK2 dosage in myeloid cells might have a role in vascular functionality and damage, we used a HFD-induced obesity model comparing control animals with those with a selective downregulation of GRK2 in this cell lineage (LysM-GRK2+/−).